- Research article
- Open Access
Patterns of sexual behaviour associated with repeated chlamydia testing and infection in men and women: a latent class analysis
BMC Public Health volume 22, Article number: 652 (2022)
Adolescents and young adults are at higher risk of acquiring Chlamydia trachomatis infection (chlamydia), so testing is promoted in these populations. Studies have shown that re-testing for chlamydia is common amongst them. We investigated how sexual risk behaviour profiles are associated with repeated testing for chlamydia.
We used baseline data from a cohort of 2814 individuals recruited at an urban STI -clinic. We applied latent class (LC) analysis using 9 manifest variables on sexual behaviour and substance use self-reported by the study participants. We fitted ordered logistic regression to investigate the association of LC membership with the outcomes repeated testing during the past 12 months and lifetime repeated testing for chlamydia. Models were fit separately for men and women.
We identified four LCs for men and three LCs for women with increasing gradient of risky sexual behaviour. The two classes with the highest risk among men were associated with lifetime repeated testing for chlamydia: adjOR = 2.26 (95%CI: 1.50–3.40) and adjOR = 3.03 (95%CI: 1.93–4.74) as compared with the class with lowest risk. In women, the class with the highest risk was associated with increased odds of repeated lifetime testing (adjOR =1.85 (95%CI: 1.24–2.76)) and repeated testing during past 12 months (adjOR = 1.72 (95%CI: 1.16–2.54)). An association with chlamydia positive test at the time of the study and during the participant’s lifetime was only found in the male highest risk classes.
Prevention messages with regard to testing for chlamydia after unprotected sexual contact with new/casual partners seem to reach individuals in highest risk behaviour classes who are more likely to test repeatedly. Further prevention efforts should involve potentially more tailored sex-specific interventions taking into consideration risk behaviour patterns.
Among bacterial sexually transmitted infections (STIs), Chlamydia trachomatis infection (chlamydia) has the highest burden globally , with the potential to cause serious reproductive health sequalae, such as pelvic inflammatory disease, ectopic pregnancy, and tubal infertility [2,3,4,5,6]. As chlamydia infection is often asymptomatic [7, 8], control measures are aimed at reducing chlamydia incidence and prevalence, as well as potential complications, through screening (testing), treatment and partner notification . Recommendations for annual chlamydia screening in Europe target sexually active individuals under 25 years of age, and those who have had a new sexual partner or more than one partner in the previous year . In the USA, similar recommendations target women, and are extended to young males with high chlamydia prevalence . Repeat testing after initial infection has been found to be beneficial, since repeated chlamydia infections are common [12,13,14], with recommendations for re-testing of chlamydia positive individuals varying between 3 and 12 months in different countries [10, 11].
Sweden has no restrictions on chlamydia testing; anyone who wishes to be tested has the opportunity to do so. The official recommendation is aimed at persons with a recent new partner or who have had unprotected sexual contact . Testing is based on opportunistic screening (testing) of adolescents and young adults aged 15–29 years, with the intention of increasing testing coverage as part of the National Action Plan for Chlamydia Prevention . The number of reported chlamydia tests increased consistently between 2009 (496522) and 2018 (591460), with chlamydia positivity dropping from 7.6 to 5.4% during the period . Interned-based testing likely contributed to this, accounting for over 20% of all chlamydia tests in 2018 .
Independent factors associated with repeated testing were reported elsewhere, that is, younger than 25 years, female sex, co-infection with HIV or gonorrhoea, and increased number of sexual partners during the previous 6 months [19,20,21]. However, it is reported that risk factors for adverse health conditions co-occur . Similarly, according to the syndemic theory, single sexual behaviours could synergistically interact with other behaviours, such as alcohol and drug use [23,24,25,26]. Therefore, classical regression analysis (i.e., variable-oriented), which looks at the association between independent variable and outcome variable while holding other variables constant is not capturing full picture. In contrast, a person-oriented analysis approach, such as latent class analysis (LCA), captures how multiple variables co-occur and interact with each other [27, 28]. This approach allows a multidimensional perspective, where sexual behaviour, substance use, and demographic variables interconnect. It can unmask subgroups (classes) of individuals within the population of interest.
We initiated the present study to gain a better knowledge about population subgroups tested repeatedly for chlamydia to contribute to the improvement of chlamydia prevention. We had two objectives: 1) to identify subgroups (latent classes) based on sexual behaviour and substance use patterns; 2) to study how membership of different latent classes is associated with repeated chlamydia testing and repeated chlamydia infection. Our hypothesis was that members of high-risk behaviour latent classes (LCs) are more likely to test repeatedly and acquire chlamydia repeatedly compared with low-risk behaviour classes.
We used data from a published cohort study at an STI-clinic in Stockholm . Visitors aged 20–39 years presenting for chlamydia testing at the clinic between December 2007 and June 2008 were invited to take part in the study. Participants signed a written consent to link their answers in a questionnaire with the result of their test for chlamydia. The questionnaire included topics on sexual behaviour, testing behaviour and experience of substance use (see Table 1S in Online supplement) prior to providing a sample for chlamydia testing . In total 2814 individuals met inclusion criteria and were included in the parent and current study.
Manifest variables of sexual behaviour and substance use of latent class membership
To identify LCs, we initially selected 12 out of 26 variables related to sexual behaviour and substance use common to men and women. Table 1S in the Online Supplement shows the original manifest variables and our reasoning for the selection for LCA based on the published literature and our expert judgement.
Variables were taken directly from the original questionnaire , however, we combined two variables to construct a new variable “Current steady relationship and concurrent sexual contacts during past 12 months” (Table 2S in Online Supplement). Another two variables, originally selected for LCA, were omitted from the final model due to collinearity or low response rate (Table 2S in Online Supplement). Furthermore, we collapsed response categories of some variables included in the LCA, since latent class models were not feasible owing to small counts in some of the initial response categories of the variables (see details in Table 2S with new categories). As a result, nine variables were included in the LCA (Table 1).
Demographic and sex-specific variables across latent classes
We described the probabilities resulting from the LCA for covariates common to men and women and for covariates specific to each sex. Common covariates were age group and marital status, while sex-specific covariates were “Got woman unintentionally pregnant” for men; and for women, “Use of contraception method”, “Use of emergency contraceptive pills”, and “History of induced abortion”.
We investigated the association between LCs and two outcomes: testing and being infected with chlamydia. For each outcome, we looked at short-term and long-term measures (Table 2). For short-term testing, we looked at repeated testing for chlamydia during the past 12 months (no/yes). For long-term testing, we analysed repeated lifetime testing for chlamydia (no; 1–3 times; four or more times). Correspondingly, for chlamydia infection short-term, we looked at current chlamydia test results at the time of recruitment (negative/positive), and for long-term outcomes, repeated lifetime chlamydia infection (never; once; twice or more times). No and never were considered as reference levels in all outcome analyses.
Due to differences in sexual behaviour, we carried out the analyses for each sex independently, and we adjusted regression models for age group (20–24, 25–29, 30–34 and 35–40 years; with the latter as a reference level).
Latent class models with varying numbers of LCs (2–6) were fitted, based on the observed 9 manifest variables (Table 1). We selected the number of LCs based on the minimal or close to minimal Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC), numerical convergence and stability of the model fit, as well as on differential interpretation of competing models. We also calculated the entropy for each LC model, where values approaching one indicate clearer separation between latent classes . The conditional response probabilities and LC prevalence were estimated using the maximum likelihood criterion. Each respondent was assigned to the LC with estimated highest latent class probability.
For interpretation and labelling LCs, we first identified for each manifest variable the response category carrying the highest risk for sexually transmitted infections (STIs). For example, for the manifest variable “Steady and Concurrent relationship” we chose the category “No steady partner and no/missing concurrent” as our highest risk category. Based on the estimated probabilities for each identified category of the variable we chose labels for the LCs (see details in Table 3S–4S in Online Supplement).
We ordered LCs according to sexual risk-behaviour for general STIs (see Table 1S for references) by considering only the same highest-risk category of each manifest variable, as used for the labelling of the LCs (see above). Thus, Class 1 comprised individuals with the lowest probabilities of highest-risk sexual behaviour and substance use (e.g., number of sexual partners 6 or more during past 12 months, alcohol use several times), which we considered as class of “lowest-risk behaviour”, and used as a reference level in all analyses. The LCs with highest probabilities of high-risk sexual behaviour and substance use were considered as “highest-risk behaviour” classes (Class 3 and 4). We assigned the remaining LC (Class 2) to the “moderate-risk behaviour” LC, since probabilities of highest-risk sexual behaviour and substance use were in between “lowest-risk behaviour” and “highest-risk behaviour” classes; see Figs. 1, 2, 3 and 4 where we present LCs in the ascending order of risk behaviour as we defined above.
We assessed the association between LC membership and distal outcomes via regression models. For the dichotomous short-term outcomes (repeated testing during 12 months, chlamydia infection at current test occasion), we fitted ordinary logistic regression models with the LCs as predictor variable, adjusted for age group. For the three-level long-term outcomes (lifetime testing for chlamydia, lifetime chlamydia infections), we first fitted proportional odds ordinal logistic regression models, again with the identified LCs as independent predictor variable and adjusted for age group . The main assumption in this model was that the relationship between all categories of the outcome is the same, i.e. proportional. This model produces one set of adjusted odds ratios that describe the relative odds of both the intermediate outcome level vs the lowest outcome level, and the highest outcome level vs the intermediate outcome level. We then tested the assumption of proportional odds via a Brant test . For the outcome “Lifetime chlamydia infection” in men, we found significant evidence that the assumption was violated, and we consequently re-fit this as a multinomial (polytomous) logistic regression model instead; this model generates two sets of odds ratios, one for the intermediate vs lowest outcome level comparison, and one for the highest vs intermediate outcome level comparison . For the long-term distal outcomes, we also performed a linear trend test (Wald test). We reported adjusted odds ratios (adjORs) with 95% confidence intervals (CIs).
We recruited 2814 individuals, of whom 1436 (51%) were men . The age of the respondents was 20 to 40 years, with a mean age for women of 27.0 (± 4.3) years and a mean age for men of 27.8 (± 4.4) years. Two thirds of men and women were single .
Latent classes by sex
Based on the nine selected manifest variables, we fitted models with two to five LCs for men and up to three LCs for women (models with more classes did not converge). Model AIC and BIC values strongly supported three classes for women, and provided strong evidence for either four or five classes for men (Online supplement Table 5S). Closer comparison of the two candidate models for men revealed some numerical instability, a less interpretable solution (not shown) and a lower entropy for the five-class model, which led us to adopt the four-class model for men (Fig. 1, Online supplement Table 5S).
We interpreted, labelled, and ordered the LCs based on the item-response probabilities (Online supplement Table 3S–4S), with Class 1 representing the least risky behaviour, and Class 4 for men and Class 3 for women the riskiest behaviour. We present the probabilities of the highest risk category of each manifest variable in Figs. 1 and 2 as support for this characterization, For men, 8% (n = 110) fell into Class 1 (lowest-risk behaviour class), labelled “Mixed steady and non-steady partnerships, low substance use”, characterized by highest probability of reporting steady partnerships, with higher probability of reporting 0–2 sexual partners, no alcohol use and very low probability of drug use (Table 3S, Fig. 1). Thirty percent (n = 441) of men fell into Class 2 (moderate-risk behaviour), labelled “Steady partnership with/without concurrent partners” which was characterized by the highest probability of reporting steady partnerships, alongside with equal probability of having/not having concurrent relationships, lower probability of reporting ≥6 sexual partners during the past 12 months, with high probability using condoms “often and always” with casual partners, with relatively high probability of using alcohol and low use of drugs. For men, we could further separate LCs of highest-risk behaviour: “Non-steady partnerships with many partners, condom users” (Class 3, n = 601) and “Non-steady partnerships with many partners, condom non-users” (Class 4, n = 284). These LCs contained 42 and 20% of the men, respectively (Table 3S, Fig. 1). These two classes were similar in their probabilities of reporting high probability of not having steady partnerships, higher probability reporting ≥6 sexual partners during past 12 months, high probability of alcohol use. The only distinguishing features were: difference in condom use “never and seldom” with casual partners (low for Class 3 and high for Class 4), which reflected also in the responsibility for condoms, and difference in drug use (low for Class 3 and higher for Class 4) (Table 3S, Fig. 1).
Among women, similar latent risk classes were observed, also in terms of size, as for men. Among women, 10% (n = 134) fell into Class 1 (lowest-risk behaviour), labelled “Mixed steady and non-steady partnerships, low substance use” and characterized by almost equal probability of reporting steady and non-steady relationships, lowest probability of reporting ≥6 sexual partners during past 12 months, lowest probability of reporting condom use “never and seldom” with casual partners, lowest probability of alcohol and drug use (Online supplement Table 4S, Fig. 2). Thirty-two percent (n = 441) of women fell into Class 2 (moderate-risk behaviour), labelled “Steady partnership with/without concurrent partners” characterized by highest probability of reporting steady partnerships alongside with equal probability of having/not having concurrent relationships, lower probability reporting ≥6 sexual partners during past 12 months, with higher probability using condoms “never and seldom” with casual partners, with relatively high probability of using alcohol and higher use of drugs (Table 4S, Fig. 2). The largest Class 3 (highest-risk behaviour), containing 58% (n = 803) of women, was labelled “Non-steady partnerships with many partners”, and was characterised by a high probability of having a non-steady current partner and a higher probability of having 6 or more sexual partners during the previous 12 months compared with the other female LCs. The probability of frequent alcohol use before sex was high among both women and men across all LCs, with the exception of Class 1.
Demographic and sex-specific variables across latent classes
Class membership was similar amongst the men and women across the age groups and marital status (Online supplement Table 6S – 7S). Notably, the younger (20–29 years of age) men (76%) and women (77%), and single men (88%) and women (96%) were more likely to belong to high-risk classes (Class 4 and 3, respectively). The men in Class 4 were also more likely (40%) to impregnate women unintentionally than men in other LCs. The absolute majority (80–87%) of women used some type of contraception across LCs. However, women in Class 3 were more likely to use the barrier method (35%). There was no major difference in the use of emergency contraceptive pills or a history of induced abortion across LCs.
Short-term outcome: repeated testing during past 12 months and current chlamydia infection
For repeated testing for chlamydia during past 12 months, we found significantly higher odds of 1.72 (95%CI: 1.16–2.54) in highest-risk behaviour Class 3 compared with Class 1 (Fig. 3, Online supplement Table 8S) among women. Among men, there was a borderline statistically non-significant association with highest-risk behaviours Class 3, adjOR = 1.60 (95%CI: 0.97–2.65), Fig. 3, Online supplement Table 9S.
Among men, Class 4 had 3.03 (95%CI 1.32–6.93) times higher odds than Class 1 of testing positive for the current chlamydia infection (Fig. 4, Online supplement Table 10S). Class 3 in men had borderline statistically non-significant increased odds as well: adjOR = 2.16 (95%CI: 0.97–4.83). None of the associations were statistically significant for this outcome among women (Fig. 4, Online supplement Table 11S).
Long- term outcome: repeated lifetime testing and repeated lifetime chlamydia infection
Both the highest-risk male classes and the highest-risk female class were all significantly associated with at least a two-fold increased odds of repeated lifetime testing (Fig. 3, Online supplement Table 8S–9S). Among men, Class 3 had an adjOR = 2.26 (95%CI: 1.50–3.40), while Class 4 had an even stronger association with adjOR =3.03 (95%CI: 1.93–4.74). Among women, we estimated 1.85 (95%CI: 1.24–2.76) higher odds of repeated lifetime testing in the highest-risk Class 3 compared to Class 1. We found a statistically significant linear trend for this outcome in both men and women, which indicated a dose-response relationship: increasing levels of risk behaviour LCs were associated with increased odds of repeated lifetime testing for chlamydia.
In contrast to the results presented above, we found that for men, the relationship between LCs varied between outcome levels (never, once, twice or more) of repeated lifetime chlamydia infection (Fig. 4, Table 10S in Online Supplement). For a comparison between outcome categories “once” versus “never”, we found an approximately linearly increasing trend across LCs, with Class 3 having 1.84 (95%CI: 1.03–3.26) higher odds than Class 1 of having had one previous chlamydia infection, and Class 4 having 2.54 (95%CI: 1.39–4.64) higher odds compared to Class 1 (red line in the corresponding panel in Fig. 4). In contrast, the odds of having chlamydia twice or more compared with having had it only once was not increased for Classes 2 and 3, and the increased odds for Class 4 were not statistically significant (OR = 2.52, 95%CI: 0.94–6.70) (blue line in the corresponding panel in Fig. 4, Online supplement Table 10S). Among women, none of the associations were statistically significant for lifetime repeated chlamydia infection (Fig. 4, Online supplement Table 11S).
In a large cohort of visitors to the STI-clinic, we identified LCs, which represented a diversity of sexual behaviour, and ranged from lowest- to highest risk sexual behaviour. Our result showed that sexual behaviours and substance use co-occur and are associated with repeated testing for chlamydia during their lifetime for both sexes and with repeated testing during the past 12 months among women. The men in the highest-risk latent classes had a two-fold higher odds of being infected once during their lifetime and a three-fold higher odds of having a current chlamydia infection. No associations between LC membership and chlamydia infection were found amongst the women.
We identified four distinct LCs for the men and three LCs for the women. The majority (60%) of respondents of both sexes fell into highest-risk behaviour LCs, which may have been expected given that the entire cohort was recruited at an STI-clinic, where a higher proportion of individuals with high-risk behaviour are more likely to be presented, as has been noted elsewhere [37,38,39]. For both sexes we saw similarities in important discriminators of class profiles, such as pre-sex alcohol use and use of other drugs (cannabis the most frequently cited). Pre-sex alcohol use can lead to poor judgement on sexual partner choice (e.g., casual partner), an increased number of sexual partners, condomless sex, and regrets about having had sex as was reported in other studies [40,41,42]. Additionally, other studies have suggested that people who fail to use condoms after drinking possibly also fail to use them when they abstain from drinking; thus, such behaviour is believed to be more likely related to personality traits [43, 44]. Combined substance use of drugs and alcohol is reported to be clustered together [45, 46] with the purpose to facilitate sexual contact and to enhance the sensations of sexual intercourse has been described previously . The variable Type of current sexual partnership (steady vs casual) was also strong discriminator of the profiles both men and women and is reported elsewhere to vary in condom use . Less successful discriminators in our class profiles were condomless sex with casual partners and number of sexual partners during the previous 12 months. However, several earlier studies have reported that respondents consider it important to use condoms and have the intention to use them, but actual use varies with the type of partner and the form of sexual contact [47,48,49,50,51]. This was reflected amongst the men in our study, where further separation of the high-risk classes was possible: one class was described as condom users (Class 3) and the other non-condom users (Class 4). An increased number of sexual partners is known independent risk factor for chlamydia [29, 52, 53] and was one of the discriminating variables in women. In our LCA, however, we found that this also co-occur with decreased condom use in highest- and moderate-risk behaviour LCs. The moderate-risk sexual behaviour class was also characterised by a high probability of concurrent (casual) partnerships, despite a high proportion of current steady partnerships. These results from our study were consistent with previous LCA studies where these factors were a significant facilitator of STI acquisition [54,55,56,57]. These identified similarities and differences in the profiles of men and women in our cohort have implications for the different approach towards these populations, which we also explored further.
We found that individuals of highest-risk classes of both sexes had a higher odds of being tested repeatedly, which supported our hypothesis. Studies have shown consistently that repeated testing may facilitate short-term change in high-risk behaviour if individuals receive positive chlamydia results [58, 59] but not negative results , suggesting that testing has unintended consequences [61,62,63]. Furthermore, a recent study suggested that young adults who engage in unsafe sex possibly have repeated tests for chlamydia as a replacement for condom use . Repeated testing for chlamydia in highest-risk classes in our study suggest that members of these LCs had absorbed Swedish public health messages to test for chlamydia after unprotected sexual contact with a new or casual partner . Recent study in Stockholm County reported (after controlling for social-economic factors and previous positive chlamydia test) that actually 42% of young people had tested repeatedly for chlamydia within a 3-year period .
Furthermore, our results also showed that relationship between latent classes and chlamydia infection differed by sex. Men in the highest-risk classes were more likely to test positive for present chlamydia and at least once during their lifetime as well as test repeatedly, which suggests that they did not change their sexual behaviour. Repeated testing after chlamydia infection due to unchanged risky behaviour has been reported elsewhere [19, 65,66,67]. Notably, another LCA study reported similar findings to ours that casual sex risk-takers (which is a feature of our latent Class 3 and 4) were more likely to contract STIs [23, 68]. Conversely, we found increased odds amongst the women for LCs 2 and 3 but not statistically significant with effect size smaller than for men. Possible reasons for that could be more consistent condom use in women than in men: in our LCA condom use variable was a better separator of LCs among men (especially Class 3 and 4) but less discriminatory in LCs for women (Figs. 1 and 2, where the most discriminatory items are at the top of the panel). Alternatively, difference in positivity by sex could be partially explained by the difference in testing pattern. Women have more encounters with health care (e.g., routine gynaecology visits, family planning counselling etc.) and therefore have better possibilities for screening for chlamydia and other STIs, while men reportedly have poorer test-seeking behaviour [18, 19].
Accessible testing for chlamydia in Sweden is well accepted by the users [64, 69]. However, it has been argued that introducing a screening program for chlamydia in low-risk populations, where many individuals test negative and might therefore change their sexual behaviour in the direction of greater risk, could hamper screening efforts . As a result, a high prevalence of repeated chlamydia infections is maintained amongst men and women [70, 71]. Furthermore, possible scaling down of testing towards only symptomatic was suggested recently . Our results indicated that risky sexual behaviour (e.g., condomless sexual contacts with casual partners, and higher numbers of sexual partners) were still at high levels amongst the men and at moderate levels for women in the highest-risk classes (Class 4 and 3, respectively), suggesting that the response to interventions might be different in each latent class. Thus, continuous condom promotion is needed as condoms are effective in reducing the risk of chlamydia and other STIs , and can reduce chlamydia prevalence substantially [74, 75]. Additionally, alcohol use was highly prevalent amongst our study participants, and therefore efforts to increase condom use could be combined with interventions to decrease alcohol use; this might encourage condom-related protective behavioural strategies in individuals [43, 76].
Our study has several strengths. Firstly, to the best of our knowledge, the present study is the first to associate sexual and substance use risk-behaviour LC membership with repeated testing for chlamydia. Additionally, our LCA was reinforced by the large sample size based on the detailed questionnaire data and the distinction it drew between the sexes. Our study has several limitations. One of the major limitations is that the data was collected in 2008 and might not reflect current behaviours or patterns of behaviours in the population of interest. Nevertheless, the subsequent studies over the years in Sweden in similar STI clinic populations  and users of internet-based testing  reported congruous independent risk behaviours associated with chlamydia infection. In addition, sexual and substance use behaviours neither changed significantly over the time in the general population [79, 80]. However, we should be careful regarding the fact whether latent class patterns nowadays would look similar to our identified LCs even if based on similar risk factors. Thus, the extrapolation of our results on LCs on current populations should be done with assumption that similar LCs are formed among individuals with the same risk factors as in our study. Another limitation is that our analysis relies on an accurate selection of observed variables to identify latent classes. Additionally, recall bias and self-report bias are common in studies based on self-reported data. Another limitation is that our study population was not randomly sampled from the general population; the fact that they were visitors at an STI-clinic suggests selection bias. Furthermore, we used different recall times for exposure (6 months and 12 months) and outcomes (12 months and across lifetime), which may have biased the observed associations. However, a recent LCA study in a similar setting reported that the majority of its population remained in the same LC for up to one year, which was an indication of relatively stable sexual behaviour . Finally, no causal inference can be drawn from the present study because of potential unmeasured confounding and a lack of temporality.
In conclusion, we supported our hypothesis that LCs of highest-risk sexual behaviour were associated with the repeated lifetime testing for chlamydia (amongst both sexes) and repeated testing during the previous 12 months (amongst the women). This suggested that public health messages regarding STI testing were being acted on. However, borderline association with repeated chlamydia infection in men of highest-risk classes suggests that they are at risk for STIs and future research should focus on effective interventions to reach these population subgroups. This analysis should be repeated on more recent data, which might provide further insight into current risk behaviour patterns and prevention needs. Our results suggest that efforts at prevention of safe sex should be stepped up with potentially more tailored sex-specific interventions and addressing different risk behaviour patterns.
Availability of data and materials
The data that support the findings of this study are available from Public Health Agency of Sweden but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of Public Health Agency of Sweden.
Akaike Information Criterion
Adjusted Odds Ratio
Bayesian Information Criterion
Latent class analysis
Sexually transmitted infection
Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10(12):e0143304. https://doi.org/10.1371/journal.pone.0143304.
Davies B, Turner KME, Frolund M, Ward H, May MT, Rasmussen S, et al. Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. Lancet Infect Dis. 2016;16(9):1057–64. https://doi.org/10.1016/S1473-3099(16)30092-5.
den Heijer CDJ, Hoebe C, Driessen JHM, Wolffs P, van den Broek IVF, Hoenderboom BM, et al. Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy, and female infertility: a retrospective cohort study among primary care patients. Clin Infect Dis. 2019;69(9):1517–25. https://doi.org/10.1093/cid/ciz429.
Hoenderboom BM, van Benthem BHB, van Bergen J, Dukers-Muijrers N, Gotz HM, Hoebe C, et al. Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial. Sex Transm Infect. 2019;95(4):300–6. https://doi.org/10.1136/sextrans-2018-053778.
Reekie J, Donovan B, Guy R, Hocking JS, Kaldor JM, Mak D, et al. Risk of ectopic pregnancy and tubal infertility following gonorrhea and Chlamydia infections. Clin Infect Dis. 2019;69(9):1621–3. https://doi.org/10.1093/cid/ciz145.
Reekie J, Donovan B, Guy R, Hocking JS, Kaldor JM, Mak DB, et al. Risk of pelvic inflammatory disease in relation to Chlamydia and gonorrhea testing, repeat testing, and positivity: a population-based cohort study. Clin Infect Dis. 2018;66(3):437–43. https://doi.org/10.1093/cid/cix769.
Detels R, Green AM, Klausner JD, Katzenstein D, Gaydos C, Handsfield H, et al. The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex Transm Dis. 2011;38(6):503–9.
Korenromp EL, Sudaryo MK, de Vlas SJ, Gray RH, Sewankambo NK, Serwadda D, et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS. 2002;13(2):91–101. https://doi.org/10.1258/0956462021924712.
European Centre for Disease Prevention and Control. Guidance on chlamydia control in Europe – 2015. Stockholm. 2016. https://doi.org/10.2900/667703. Available from: http://ecdc.europa.eu/en/publications/Publications/chlamydia-control-europe-guidance.pdf.
Lanjouw E, Ouburg S, de Vries HJ, Stary A, Radcliffe K, Unemo M. 2015 European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS. 2016;27(5):333–48. https://doi.org/10.1177/0956462415618837.
Workowski KA, Bolan GA, Centers for Disease C, Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommend Rep. 2015;64(RR-03):1–137.
Gotz HM, Wolfers ME, Luijendijk A, van den Broek IV. Retesting for genital Chlamydia trachomatis among visitors of a sexually transmitted infections clinic: randomized intervention trial of home- versus clinic-based recall. BMC Infect Dis. 2013;13:239. https://doi.org/10.1186/1471-2334-13-239.
Klovstad H, Natas O, Tverdal A, Aavitsland P. Systematic screening with information and home sampling for genital Chlamydia trachomatis infections in young men and women in Norway: a randomized controlled trial. BMC Infect Dis. 2013;13:30. https://doi.org/10.1186/1471-2334-13-30.
van der Helm JJ, Koekenbier RH, van Rooijen MS, van der Loeff MF S, de Vries HJC. What is the optimal time to retest patients with a urogenital Chlamydia infection? A randomized controlled trial. Sex Transm Dis. 2018;45(2):132–7. https://doi.org/10.1097/OLQ.0000000000000706.
Läkemedelsverket (Swedish Medical Products Agency). Sexuellt överförbara bakteriella infektioner - behandlingsrekommendation: Läkemedelsverket. 2015. In Swedish. Available from: https://lakemedelsverket.se/sti.
The National Board of Health and Welfare of Sweden. The National Action Plan for Chlamydia Prevention with focus on young people aged 15–29 years. Stockholm. 2009. Report No.: 2009–126-180. In Swedish.
Folkhälsomyndigheten. Klamydiainfektion 2019. Folkhälsomyndigheten, Stockholm, Sweden. 2019. https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistik-a-o/sjukdomsstatistik/klamydiainfektion/?p=76949#statistics-nav. Accessed December 15, 2020.
Soderqvist J, Gullsby K, Stark L, Wikman M, Karlsson R, Herrmann B. Internet-based self-sampling for Chlamydia trachomatis testing: a national evaluation in Sweden. Sex Transm Infect. 2020;96(3):160–5. https://doi.org/10.1136/sextrans-2019-054256.
Nielsen A, Marrone G, De Costa A. Chlamydia trachomatis among youth - testing behaviour and incidence of repeat testing in Stockholm County, Sweden 2010-2012. PLoS One. 2016;11(9):e0163597. https://doi.org/10.1371/journal.pone.0163597.
Visser M, van Aar F, Koedijk FDH, Kampman CJG, Heijne JCM. Repeat Chlamydia trachomatis testing among heterosexual STI outpatient clinic visitors in the Netherlands: a longitudinal study. BMC Infect Dis. 2017;17(1):782. https://doi.org/10.1186/s12879-017-2871-1.
Wijers J, Dukers-Muijrers N, Hoebe C, Wolffs PFG, van Liere G. The characteristics of patients frequently tested and repeatedly infected with Chlamydia trachomatis in Southwest Limburg, the Netherlands. BMC Public Health. 2020;20(1):1239. https://doi.org/10.1186/s12889-020-09334-9.
Collaborators GBDRF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1923–94. https://doi.org/10.1016/S0140-6736(18)32225-6.
Hill AV, De Genna NM, Perez-Patron MJ, Gilreath TD, Tekwe C, Taylor BD. Identifying Syndemics for sexually transmitted infections among young adults in the United States: a latent class analysis. J Adolesc Health. 2019;64(3):319–26. https://doi.org/10.1016/j.jadohealth.2018.09.006.
Konda KA, Celentano DD, Kegeles S, Coates TJ, Caceres CF, Group NCHSPT. Latent class analysis of sexual risk patterns among esquineros (street corner men) a group of heterosexually identified, socially marginalized men in urban coastal Peru. AIDS Behav. 2011;15(4):862–8. https://doi.org/10.1007/s10461-010-9772-2.
Nelon JL, De Pedro KT, Gilreath TD, Patterson MS, Holden CB, Esquivel CH. A latent class analysis of the co-occurrence of sexual violence, substance use, and mental health in youth. Subst Use Misuse. 2019;54(12):1938–44. https://doi.org/10.1080/10826084.2019.1618337.
Singer MC, Erickson PI, Badiane L, Diaz R, Ortiz D, Abraham T, et al. Syndemics, sex and the city: understanding sexually transmitted diseases in social and cultural context. Soc Sci Med. 2006;63(8):2010–21. https://doi.org/10.1016/j.socscimed.2006.05.012.
Collins LM, Lanza ST. Latent class and latent transition analysis. Wiley series in probability and statistics. Hoboken, New Jersey: John Wiley & Sons, Inc.; 2010.
Formann AK, Kohlmann T. Latent class analysis in medical research. Stat Methods Med Res. 1996;5(2):179–211. https://doi.org/10.1177/096228029600500205.
Velicko I, Ploner A, Sparen P, Marions L, Herrmann B, Kuhlmann-Berenzon S. Sexual and testing behaviour associated with Chlamydia trachomatis infection: a cohort study in an STI clinic in Sweden. BMJ Open. 2016;6(8):e011312. https://doi.org/10.1136/bmjopen-2016-011312.
Edgardh K, Kuhlmann-Berenzon S, Grunewald M, Rotzen-Ostlund M, Qvarnstrom I, Everljung J. Repeat infection with Chlamydia trachomatis: a prospective cohort study from an STI-clinic in Stockholm. BMC Public Health. 2009;9:198. https://doi.org/10.1186/1471-2458-9-198.
Aldana-Bobadilla E, Kuri-Morales A. A clustering method based on the maximum entropy principle. Entropy. 2015;17(1):151–80. https://doi.org/10.3390/e17010151.
Bender R, Grouven U. Ordinal logistic regression in medical research. J R Coll Physicians Lond. 1997;31(5):546–51.
Richard W. Generalized ordered logit/partial proportional odds models for ordinal dependent variables. Stata J. 2006;6(1):58–82.
Kwak C, Clayton-Matthews A. Multinomial logistic regression. Nurs Res. 2002;51(6):404–10. https://doi.org/10.1097/00006199-200211000-00009.
STATA version 15. Stata statistical software: release 15. College Station, TX: Stata Corp LLC; 2017.
R Core Team. R. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017.
van Wees DA, Heijne JCM, Basten M, Heijman T, de Wit J, Kretzschmar MEE, et al. Longitudinal patterns of sexually transmitted infection risk based on psychological characteristics and sexual behavior in heterosexual sexually transmitted infection clinic visitors. Sex Transm Dis. 2020;47(3):171–6. https://doi.org/10.1097/OLQ.0000000000001110.
Vasilenko SA, Kugler KC, Butera NM, Lanza ST. Patterns of adolescent sexual behavior predicting young adult sexually transmitted infections: a latent class analysis approach. Arch Sex Behav. 2015;44(3):705–15. https://doi.org/10.1007/s10508-014-0258-6.
Xu Y, Norton S, Rahman Q. Adolescent sexual behavior patterns in a British birth cohort: a latent class analysis. Arch Sex Behav. 2021;50(1):161–80. https://doi.org/10.1007/s10508-019-01578-w.
Bellis MA, Hughes K, Calafat A, Juan M, Ramon A, Rodriguez JA, et al. Sexual uses of alcohol and drugs and the associated health risks: a cross sectional study of young people in nine European cities. BMC Public Health. 2008;8:155. https://doi.org/10.1186/1471-2458-8-155.
George WH. Alcohol and sexual health behavior: "what we know and how we know it". J Sex Res. 2019;56(4–5):409–24. https://doi.org/10.1080/00224499.2019.1588213.
Griffin JA, Umstattd MR, Usdan SL. Alcohol use and high-risk sexual behavior among collegiate women: a review of research on alcohol myopia theory. J Am Coll Heal. 2010;58(6):523–32. https://doi.org/10.1080/07448481003621718.
Moylett S, Hughes BM. The associations among personality, alcohol-related protective Behavioural strategies (PBS), alcohol consumption and sexual intercourse in Irish, female college students. Addict Behav Rep. 2017;6:56–64. https://doi.org/10.1016/j.abrep.2017.08.001.
Weinhardt LS, Carey MP. Does alcohol lead to sexual risk behavior? Findings from event-level research. Ann Rev Sex Res. 2000;11:125–57.
Assanangkornchai S, Li J, McNeil E, Saingam D. Clusters of alcohol and drug use and other health-risk behaviors among Thai secondary school students: a latent class analysis. BMC Public Health. 2018;18(1):1272. https://doi.org/10.1186/s12889-018-6205-z.
Martin CE, Ksinan AJ, Moeller FG, Dick D. Spit for science working G. sex-specific risk profiles for substance use among college students. Brain Behav. 2021;11(2):e01959. https://doi.org/10.1002/brb3.1959.
Lescano CM, Vazquez EA, Brown LK, Litvin EB, Pugatch D, Project SSG. Condom use with "casual" and "main" partners: what's in a name? J Adolesc Health. 2006;39(3):443 e1–7. https://doi.org/10.1016/j.jadohealth.2006.01.003.
Darj E, Bondestam K. Adolescents' view on the use of condoms. Lakartidningen. 2003;100(44):3510–2 5–6.
Eleftheriou A, Bullock S, Graham CA, Skakoon-Sparling S, Ingham R. Does attractiveness influence condom use intentions in women who have sex with men? PLoS One. 2019;14(5):e0217152. https://doi.org/10.1371/journal.pone.0217152.
Fridlund V, Stenqvist K, Nordvik MK. Condom use: the discrepancy between practice and behavioral expectations. Scand J Public Health. 2014;42(8):759–65. https://doi.org/10.1177/1403494814550518.
Senn TE, Scott-Sheldon LA, Carey MP. Relationship-specific condom attitudes predict condom use among STD clinic patients with both primary and non-primary partners. AIDS Behav. 2014;18(8):1420–7. https://doi.org/10.1007/s10461-014-0726-y.
de Coul EL, Warning TD, Koedijk FD, Dutch STIc. Sexual behaviour and sexually transmitted infections in sexually transmitted infection clinic attendees in the Netherlands, 2007-2011. Int J STD AIDS. 2014;25(1):40–51. https://doi.org/10.1177/0956462413491736.
Sonnenberg P, Clifton S, Beddows S, Field N, Soldan K, Tanton C, et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of sexual attitudes and lifestyles (Natsal). Lancet. 2013;382(9907):1795–806. https://doi.org/10.1016/S0140-6736(13)61947-9.
Hock-Long L, Henry-Moss D, Carter M, Hatfield-Timajchy K, Erickson PI, Cassidy A, et al. Condom use with serious and casual heterosexual partners: findings from a community venue-based survey of young adults. AIDS Behav. 2013;17(3):900–13. https://doi.org/10.1007/s10461-012-0177-2.
Nesoff ED, Dunkle K, Lang D. The impact of condom use negotiation self-efficacy and partnership patterns on consistent condom use among college-educated women. Health Educ Behav. 2016;43(1):61–7. https://doi.org/10.1177/1090198115596168.
Rodrigues DL, Prada M, Lopes D. Perceived sexual self-control and condom use with primary and casual sex partners: age and relationship agreement differences in a Portuguese sample. Psychol Health. 2019;34(10):1231–49. https://doi.org/10.1080/08870446.2019.1603384.
Yamamoto N, Ejima K, Nishiura H. Modelling the impact of correlations between condom use and sexual contact pattern on the dynamics of sexually transmitted infections. Theor Biol Med Model. 2018;15(1):6. https://doi.org/10.1186/s12976-018-0078-9.
Crosby RA, DiClemente RJ, Wingood GM, Salazar LF, Rose E, Levine D, et al. Associations between sexually transmitted disease diagnosis and subsequent sexual risk and sexually transmitted disease incidence among adolescents. Sex Transm Dis. 2004;31(4):205–8. https://doi.org/10.1097/01.olq.0000114940.07793.20.
Diclemente RJ, Wingood GM, Sionean C, Crosby R, Harrington K, Davies S, et al. Association of adolescents' history of sexually transmitted disease (STD) and their current high-risk behavior and STD status: a case for intensifying clinic-based prevention efforts. Sex Transm Dis. 2002;29(9):503–9. https://doi.org/10.1097/00007435-200209000-00002.
Soetens LC, van Benthem BH, Op de Coul EL. Chlamydia test results were associated with sexual risk behavior change among participants of the Chlamydia screening implementation in the Netherlands. Sex Transm Dis. 2015;42(3):109–14. https://doi.org/10.1097/OLQ.0000000000000234.
Sznitman S, Stanton BF, Vanable PA, Carey MP, Valois RF, Brown LK, et al. Long term effects of community-based STI screening and mass media HIV prevention messages on sexual risk behaviors of African American adolescents. AIDS Behav. 2011;15(8):1755–63. https://doi.org/10.1007/s10461-011-9946-6.
Sznitman SR, Carey MP, Vanable PA, DiClemente RJ, Brown LK, Valois RF, et al. The impact of community-based sexually transmitted infection screening results on sexual risk behaviors of African American adolescents. J Adolesc Health. 2010;47(1):12–9. https://doi.org/10.1016/j.jadohealth.2009.12.024.
van Wees DA, Drissen M, den Daas C, Heijman T, Kretzschmar MEE, Heijne JCM. The impact of STI test results and face-to-face consultations on subsequent behavior and psychological characteristics. Prev Med. 2020;139:106200. https://doi.org/10.1016/j.ypmed.2020.106200.
Nielsen A, De Costa A, Danielsson KG, Salazar M. Repeat testing for chlamydia trachomatis, a "safe approach" to unsafe sex? A qualitative exploration among youth in Stockholm. BMC Health Serv Res. 2017;17(1):730. https://doi.org/10.1186/s12913-017-2681-6.
Rose SB, Garrett SM, Stanley J, Pullon SRH. Retesting and repeat positivity following diagnosis of Chlamydia trachomatis and Neisseria gonorrhoea in New Zealand: a retrospective cohort study. BMC Infect Dis. 2017;17(1):526. https://doi.org/10.1186/s12879-017-2635-y.
Wijers J, Hoebe C, Dukers-Muijrers N, Wolffs P, van Liere G. The Characteristics of Patients Frequently Tested and Repeatedly Infected with Neisseria gonorrhoeae. Int J Environ Res Public Health. 2020;17(5). https://doi.org/10.3390/ijerph17051495.
Woodhall SC, Atkins JL, Soldan K, Hughes G, Bone A, Gill ON. Repeat genital Chlamydia trachomatis testing rates in young adults in England, 2010. Sex Transm Infect. 2013;89(1):51–6. https://doi.org/10.1136/sextrans-2012-050490.
Ann LH. Heterosexual casual sex and STI diagnosis: a latent class analysis. Int J Sex Health. 2017;29(1):32–47. https://doi.org/10.1080/19317611.2016.1210711.
Novak D, Novak M. Use of the internet for home testing for Chlamydia trachomatis in Sweden: who are the users? Int J STD AIDS. 2012;23(2):83–7. https://doi.org/10.1258/ijsa.2011.011030.
Fung M, Scott KC, Kent CK, Klausner JD. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect. 2007;83(4):304–9. https://doi.org/10.1136/sti.2006.024059.
Hosenfeld CB, Workowski KA, Berman S, Zaidi A, Dyson J, Mosure D, et al. Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis. 2009;36(8):478–89. https://doi.org/10.1097/OLQ.0b013e3181a2a933.
van Bergen J, Hoenderboom BM, David S, Deug F, Heijne JCM, van Aar F, et al. Where to go to in chlamydia control? From infection control towards infectious disease control. Sex Transm Infect. 2021;97(7):501–6. https://doi.org/10.1136/sextrans-2021-054992.
Warner L, Stone KM, Macaluso M, Buehler JW, Austin HD. Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis. 2006;33(1):36–51. https://doi.org/10.1097/01.olq.0000187908.42622.fd.
Azizi A, Rios-Soto K, Mubayi A, J MH. A risk-based model for predicting the impact of using condoms on the spread of sexually transmitted infections. Infect Dis Model. 2017;2(1):100–12. https://doi.org/10.1016/j.idm.2017.02.004.
Kretzschmar M, van Duynhoven YT, Severijnen AJ. Modeling prevention strategies for gonorrhea and Chlamydia using stochastic network simulations. Am J Epidemiol. 1996;144(3):306–17. https://doi.org/10.1093/oxfordjournals.aje.a008926.
Gilmore AK, Granato HF, Lewis MA. The use of drinking and condom-related protective strategies in association with condom use and sex-related alcohol use. J Sex Res. 2013;50(5):470–9. https://doi.org/10.1080/00224499.2011.653607.
Carre H, Lindstrom R, Boman J, Janlert U, Lundqvist L, Nylander E. Asking about condom use: a key to individualized care when screening for chlamydia. Int J STD AIDS. 2011;22(8):436–41. https://doi.org/10.1258/ijsa.2011.010481.
Novak M, Novak D. Risk factors for Chlamydia trachomatis infection among users of an internet-based testing service in Sweden. Sex Reprod Healthcare. 2013;4(1):23–7. https://doi.org/10.1016/j.srhc.2012.11.004.
Public health agency of Sweden. Sexuality and health among young people in Sweden. UngKAB15 – a survey on knowledge, attitudes and behaviour among young people 16–29 years old. 2017. Report No.: 02930–2017. Available from: https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/s/sexuality-and-health-among-young-people-in-sweden/.
Tikkanen RH AJ, Forsberg M. UngKAB09 - Kunskap, attityder och sexuella handlingar bland unga: Göteborgs Universitet. 2011. Report No: ISBN 978-9186796-79-2. In Swedish. Available from: https://gupea.ub.gu.se/bitstream/2077/25017/2/gupea_2077_25017_2.pdf.
We thank two anonymous reviewers for the very helpful comments.
Open access funding provided by Karolinska Institute.
Ethics approval and consent to participate
Was granted by Regional Ethics Review Board in Stockholm (reference number: 2007/933–31/4 and 2011/313–32). No administrative permissions were required to access the raw data used in this study.
Consent for publication
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Veličko, I., Ploner, A., Marions, L. et al. Patterns of sexual behaviour associated with repeated chlamydia testing and infection in men and women: a latent class analysis. BMC Public Health 22, 652 (2022). https://doi.org/10.1186/s12889-021-12394-0
- Latent class analysis
- Sexual behaviour patterns
- Testing for Chlamydia trachomatis
- Ordered logistic regression
- Stratified analysis by sex